Your browser doesn't support javascript.
Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial.
Akram, Javed; Azhar, Shehnoor; Shahzad, Muhammad; Latif, Waqas; Khan, Khalid Saeed.
  • Akram J; Vice Chancellor/Professor of Internal Medicine, University of Health Sciences, Lahore, Pakistan.
  • Azhar S; Assistant Professor Public Health, University of Health Sciences, Lahore, Pakistan. shehnoor.azhar@gmail.com.
  • Shahzad M; Professor of Pharmacology, University of Health Sciences, Lahore, Pakistan.
  • Latif W; Data Analyst at University of Health Sciences, Lahore, Pakistan.
  • Khan KS; Distinguished Investigator at Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
Trials ; 21(1): 733, 2020 08 22.
Article in English | MEDLINE | ID: covidwho-736434
ABSTRACT
An amendment to this paper has been published and can be accessed via the original article.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2020 Document Type: Article Affiliation country: S13063-020-04697-1

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2020 Document Type: Article Affiliation country: S13063-020-04697-1